MBBP Client Harvard Making Breakthroughs in Blood Stem Cell Research

Harvard University has recently completed a license agreement with Magenta Therapeutics, a newly launched start-up in Cambridge, Massachusetts, in order to continue research and development related to new approaches to blood stem cell transplantation. The deal will help transform this science from that of a "last resort" into safer, more effective therapy for patients who suffer from blood diseases, …

Continue reading MBBP Client Harvard Making Breakthroughs in Blood Stem Cell Research